Next Chems

Latest sync: Jul 12, 2026, 11:42 PM. Source coverage currently reflects PB Evidence data.

Curated

10% off with disclosed code

Disclosed partner
Coupon code 10% off

PeptideBenchmark has a disclosed affiliate relationship with Next Chems. This does not change benchmark scores or trust ratings — it only affects outbound links and pricing-board discount modeling where applicable.

Transparency type
Public document layer
Access pattern
Publicly inspectable
Best for

Readers who want the vendor represented with real structured pricing plus at least a confirmed public documentation trail, even if that trust trail is still relatively thin.

Watch-out

The pricing surface is stronger than the current public trust surface. Readers should treat Next Chems as a vendor with partial public documentation, not as a leader in catalog-wide verification transparency.

Included because it now has real structured coverage: a public product sitemap, live product-page pricing, and a small but genuine public lab-results surface.

A mixed but still legitimate public case. Next Chems exposes a browsable public storefront with product-level pricing and inline dosage variants, while the trust side currently rests on a narrow public COA page plus repeated product-page “COA available” language rather than a broad certificate archive.

Testing transparency
Vendor-hosted public documents
Public Docs
Publicly inspectable
Partial public lab-results archive

Next Chems currently exposes a small public lab-results / COAs page with vendor-hosted PDFs, and many product pages also make an explicit public COA-available claim. That is enough to create a real trust profile, but it is still much narrower than the broad archive or provider-run verification patterns we treat as stronger proof tiers.

Products reviewed
48
Products with certificates
4
Coverage ratio
8%
Avg certs / covered product
1

This vendor is one of 50 names currently included in our manual curated research-vendor layer.

View curated vendor page View transparency view View compare page

This is a meaningful public transparency pattern, but the documents are still mostly hosted on the vendor side. That makes it stronger than generic claims and weaker than provider-controlled verification.

  • Reward the fact that readers can inspect real files without logging in.
  • Pay attention to whether the archive is broad, multi-category, or repeated across many products.
  • Keep in mind that vendor-hosted files are different from a live third-party verification portal.
Read transparency methodology Browse similar transparency patterns

This vendor makes the most sense when you compare it to other vendors using a similar transparency model, rather than to every vendor on the board at once.

Open vendor compare Open vendor/provider bridge

PB Curated Assessment is a PeptideBenchmark-authored rubric built from the trust and transparency review layer. It is separate from the source-derived benchmark score.

Promising curated case

Next Chems has enough public trust structure to be useful in the curated set, even if it is not one of the clearest verification leaders yet.

Evidence access
Open public documents
Verification structure
Structured public archive
Evidence depth
Broad
Lab context
Some named lab context
Evidence access
Open public documents

Readers can inspect real public documents, even if the vendor still hosts most of the archive.

Verification structure
Structured public archive

The trust layer is structured and inspectable, but still mostly vendor-controlled.

Evidence depth
Broad

Current review touched 48 products and 50 document/link destinations.

Lab context
Some named lab context

0 named lab signal(s) and 1 certification category signal(s) are currently visible in the reviewed evidence.

How to read this benchmark

This profile summarizes public benchmark data synced from Finnrick and, when available, Peptide Critic. Finnrick contributes a 10-point average from its vendor table, while Peptide Critic contributes a 5-star rating that we normalize to a 10-point scale before ranking consensus entries.

A high score can be directionally useful, but it is not a substitute for current COAs, identity testing, chain-of-custody details, or your own due diligence. We are intentionally separating source aggregation from first-party editorial claims.

Scores combine PB trust evidence with external signals from Finnrick, Peptide Critic, Trustpilot, and Pep Review Pro when available.